These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4721643)

  • 21. Tablet disintegration and drug dissolution in viscous media: paracetamol IR tablets.
    Parojcić J; Vasiljević D; Ibrić S; Djurić Z
    Int J Pharm; 2008 May; 355(1-2):93-9. PubMed ID: 18226480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
    Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
    Dokoumetzidis A; Kalantzi L; Fotaki N
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partitioning phenomena in dosage form and biopharmaceutical design. 3. Some partitioning considerations in drug absorption, distribution, response and elimination.
    Schumacher GE
    Am J Hosp Pharm; 1972 Apr; 29(4):339-43. PubMed ID: 5025265
    [No Abstract]   [Full Text] [Related]  

  • 25. Bioequivalence of drug products.
    Koritz GD
    J Am Vet Med Assoc; 1980 Aug; 177(3):279-81. PubMed ID: 7440334
    [No Abstract]   [Full Text] [Related]  

  • 26. [Apparatus for the in vitro study of drug absorption].
    Bastide R; Rouffiac R; Stanislas E
    Pharm Acta Helv; 1972 May; 47(5):295-303. PubMed ID: 5045746
    [No Abstract]   [Full Text] [Related]  

  • 27. Commentary on AAPS Workshop: dissolution testing for the twenty-first century: linking critical quality attributes and critical process parameters to clinically relevant dissolution.
    Tong C; D'Souza SS; Parker JE; Mirza T
    Pharm Res; 2007 Sep; 24(9):1603-7. PubMed ID: 17385013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspects of pharmacokinetics and biopharmaceutics in relation to drug activity.
    Wagner JG
    Am J Pharm Sci Support Public Health; 1969; 141(1):5-20. PubMed ID: 5776857
    [No Abstract]   [Full Text] [Related]  

  • 29. Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective.
    Chen ML
    Adv Drug Deliv Rev; 2008 Mar; 60(6):768-77. PubMed ID: 18077051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward an increased understanding of the barriers to colonic drug absorption in humans: implications for early controlled release candidate assessment.
    Tannergren C; Bergendal A; Lennernäs H; Abrahamsson B
    Mol Pharm; 2009; 6(1):60-73. PubMed ID: 19183105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory aspects of drug dissolution from a European perspective.
    Graffner C
    Eur J Pharm Sci; 2006 Nov; 29(3-4):288-93. PubMed ID: 16950606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Irregular absorption profiles observed from diclofenac extended release tablets can be predicted using a dissolution test apparatus that mimics in vivo physical stresses.
    Garbacz G; Wedemeyer RS; Nagel S; Giessmann T; Mönnikes H; Wilson CG; Siegmund W; Weitschies W
    Eur J Pharm Biopharm; 2008 Oct; 70(2):421-8. PubMed ID: 18582568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.
    Brockmeier D; von Hattingberg HM
    Arzneimittelforschung; 1982; 32(3):248-51. PubMed ID: 6896279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro drug release rate as a standard requirement.
    Láng B
    Pharmazie; 1971 Nov; 26(11):661-4. PubMed ID: 5154319
    [No Abstract]   [Full Text] [Related]  

  • 35. Dissolution test development for complex veterinary dosage forms: oral boluses.
    Fahmy R; Marnane B; Bensley D; Hollenbeck RG
    AAPS PharmSci; 2002; 4(4):E35. PubMed ID: 12646007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dissolution rate for predicting physiological availability of drugs from solid dosage forms.
    Timoney RF
    Ir J Med Sci; 1968 Feb; 7(2):79-82. PubMed ID: 5653821
    [No Abstract]   [Full Text] [Related]  

  • 37. Analytical derivation of time required for dissolution of monodisperse drug particles.
    Sertsou G
    J Pharm Sci; 2004 Aug; 93(8):1941-4. PubMed ID: 15236444
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acid-base titrations of pharmaceutical preparations in non-aqueous solutions].
    Georgievs'kiĭ VP; Dziuba NP
    Farm Zh; 1968; 23(2):79-90. PubMed ID: 4894164
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the absorption of practically water-insoluble drugs following injection. I. Intramuscular absorption from water-immiscible oil solutions in rats.
    Hirano K; Ichihashi T; Yamada H
    Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):519-31. PubMed ID: 7273251
    [No Abstract]   [Full Text] [Related]  

  • 40. Intramuscular absorption of drugs from oily solutions in the rat.
    Tanaka T; Kobayashi H; Okumura K; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1974 Jun; 22(6):1275-84. PubMed ID: 4417722
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.